<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02402127</url>
  </required_header>
  <id_info>
    <org_study_id>CLT567-P001</org_study_id>
    <nct_id>NCT02402127</nct_id>
  </id_info>
  <brief_title>Lubricity Post-Wear - Competitive Lenses Pilot</brief_title>
  <official_title>Evaluation of the Lubricity of Daily Disposable Silicone Hydrogel Contact Lenses After Wear</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure the coefficient of friction of three silicone
      hydrogel, daily disposable contact lenses after 16 hours of wear.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this 3-treatment, 3-period, 6-sequence crossover study, each participant will wear all 3
      products in randomized order, 1 product at a time, with a washout period of up to 7 days
      between treatment periods. Lenses will be collected for ex-vivo lubricity analysis. The
      ex-vivo lubricity analysis will be conducted under a separate non-clinical protocol.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average Coefficient of Friction of Worn Lenses at 16 Hours</measure>
    <time_frame>Day 1, Hour 16, each product</time_frame>
    <description>Worn contact lenses were removed from the participant's eye and the coefficient of friction was measured by the inclined plane method. A lower coefficient of friction may indicate higher contact lens lubricity. The ex-vivo lubricity was carried out on one lens (one eye) only.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average Coefficient of Friction of Unworn Lenses</measure>
    <time_frame>Day 1 (each product)</time_frame>
    <description>Unworn contact lenses were removed from the commercial packaging and the coefficient of friction of the unworn lenses was measured by the inclined plane method. A lower coefficient of friction may indicate higher contact lens lubricity.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Refractive Error</condition>
  <arm_group>
    <arm_group_label>TruEye, MyDay, clariti 1day</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Narafilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3. Each product worn bilaterally (in both eyes) for 1 day (16 hours).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TruEye, clariti 1day, MyDay</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Narafilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MyDay, TruEye, clariti 1day</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Stenfilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MyDay, clariti 1day, TruEye</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Stenfilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clariti 1day, TruEye, MyDay</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Somofilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clariti 1day, MyDay, TruEye</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Somofilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3. Each product worn bilaterally for 1 day (16 hours).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Narafilcon A contact lenses</intervention_name>
    <description>Silicone hydrogel contact lenses for daily disposable wear</description>
    <arm_group_label>TruEye, MyDay, clariti 1day</arm_group_label>
    <arm_group_label>TruEye, clariti 1day, MyDay</arm_group_label>
    <arm_group_label>MyDay, TruEye, clariti 1day</arm_group_label>
    <arm_group_label>MyDay, clariti 1day, TruEye</arm_group_label>
    <arm_group_label>Clariti 1day, TruEye, MyDay</arm_group_label>
    <arm_group_label>Clariti 1day, MyDay, TruEye</arm_group_label>
    <other_name>1-DAY ACUVUE® TruEye® (TruEye)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stenfilcon A contact lenses</intervention_name>
    <description>Silicone hydrogel contact lenses for daily disposable wear</description>
    <arm_group_label>TruEye, MyDay, clariti 1day</arm_group_label>
    <arm_group_label>TruEye, clariti 1day, MyDay</arm_group_label>
    <arm_group_label>MyDay, TruEye, clariti 1day</arm_group_label>
    <arm_group_label>MyDay, clariti 1day, TruEye</arm_group_label>
    <arm_group_label>Clariti 1day, TruEye, MyDay</arm_group_label>
    <arm_group_label>Clariti 1day, MyDay, TruEye</arm_group_label>
    <other_name>MyDay™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Somofilcon A contact lenses</intervention_name>
    <description>Silicone hydrogel contact lenses for daily disposable wear</description>
    <arm_group_label>TruEye, MyDay, clariti 1day</arm_group_label>
    <arm_group_label>TruEye, clariti 1day, MyDay</arm_group_label>
    <arm_group_label>MyDay, TruEye, clariti 1day</arm_group_label>
    <arm_group_label>MyDay, clariti 1day, TruEye</arm_group_label>
    <arm_group_label>Clariti 1day, TruEye, MyDay</arm_group_label>
    <arm_group_label>Clariti 1day, MyDay, TruEye</arm_group_label>
    <other_name>clariti® 1day</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must sign an informed consent form.

          -  Soft contact lens wearer (both eyes).

          -  Willing to wear study lenses at least 16 waking hours and attend all study visits.

          -  Other protocol-specified inclusion criteria may apply.

        Exclusion Criteria:

          -  Ocular anterior segment infection, inflammation, abnormality, or active disease that
             would contraindicate contact lens wear.

          -  Use of systemic or ocular medications for which contact lens wear could be
             contraindicated.

          -  Use of artificial tears and rewetting drops during the study.

          -  Monocular (only 1 eye with functional vision) or fit with only 1 lens.

          -  History of herpetic keratitis, ocular surgery, or irregular cornea.

          -  Pregnant.

          -  Other protocol-specified exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Manager, Vision Care, Global Medical Affairs</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2015</study_first_submitted>
  <study_first_submitted_qc>March 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2015</study_first_posted>
  <results_first_submitted>July 25, 2016</results_first_submitted>
  <results_first_submitted_qc>July 25, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 2, 2016</results_first_posted>
  <last_update_submitted>July 25, 2016</last_update_submitted>
  <last_update_submitted_qc>July 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contact lenses</keyword>
  <keyword>Lubricity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from three investigational centers located in the United States.</recruitment_details>
      <pre_assignment_details>All enrolled participants (24)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>TruEye, MyDay, Clariti 1day</title>
          <description>Narafilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3</description>
        </group>
        <group group_id="P2">
          <title>TruEye, Clariti 1day, MyDay</title>
          <description>Narafilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3</description>
        </group>
        <group group_id="P3">
          <title>MyDay, TruEye, Clariti 1day</title>
          <description>Stenfilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3</description>
        </group>
        <group group_id="P4">
          <title>MyDay, Clariti 1day, TruEye</title>
          <description>Stenfilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3</description>
        </group>
        <group group_id="P5">
          <title>Clariti 1day, TruEye, MyDay</title>
          <description>Somofilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3</description>
        </group>
        <group group_id="P6">
          <title>Clariti 1day, MyDay, TruEye</title>
          <description>Somofilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Wear Period (1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Randomized and Treated</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Wear Period (1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Third Wear Period (1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Intention to treat, defined as the set of all randomized participants</population>
      <group_list>
        <group group_id="B1">
          <title>TruEye, MyDay, Clariti 1day</title>
          <description>Narafilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3</description>
        </group>
        <group group_id="B2">
          <title>TruEye, Clariti 1day, MyDay</title>
          <description>Narafilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3</description>
        </group>
        <group group_id="B3">
          <title>MyDay, TruEye, Clariti 1day</title>
          <description>Stenfilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and somofilcon A contact lenses in Period 3</description>
        </group>
        <group group_id="B4">
          <title>MyDay, Clariti 1day, TruEye</title>
          <description>Stenfilcon A contact lenses in Period 1, followed by somofilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3</description>
        </group>
        <group group_id="B5">
          <title>Clariti 1day, TruEye, MyDay</title>
          <description>Somofilcon A contact lenses in Period 1, followed by narafilcon A contact lenses in Period 2 and stenfilcon A contact lenses in Period 3</description>
        </group>
        <group group_id="B6">
          <title>Clariti 1day, MyDay, TruEye</title>
          <description>Somofilcon A contact lenses in Period 1, followed by stenfilcon A contact lenses in Period 2 and narafilcon A contact lenses in Period 3</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="4"/>
            <count group_id="B4" value="4"/>
            <count group_id="B5" value="4"/>
            <count group_id="B6" value="4"/>
            <count group_id="B7" value="24"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.0" spread="9.6"/>
                    <measurement group_id="B2" value="27.5" spread="4.0"/>
                    <measurement group_id="B3" value="33.0" spread="7.3"/>
                    <measurement group_id="B4" value="35.3" spread="4.6"/>
                    <measurement group_id="B5" value="26.3" spread="6.2"/>
                    <measurement group_id="B6" value="24.3" spread="2.4"/>
                    <measurement group_id="B7" value="30.0" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>18-64 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>≥65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Average Coefficient of Friction of Worn Lenses at 16 Hours</title>
        <description>Worn contact lenses were removed from the participant's eye and the coefficient of friction was measured by the inclined plane method. A lower coefficient of friction may indicate higher contact lens lubricity. The ex-vivo lubricity was carried out on one lens (one eye) only.</description>
        <time_frame>Day 1, Hour 16, each product</time_frame>
        <population>Intention to treat participants with non-missing observations</population>
        <group_list>
          <group group_id="O1">
            <title>TruEye</title>
            <description>Narafilcon A contact lenses worn for 16 hours in Period 1, Period 2, or Period 3</description>
          </group>
          <group group_id="O2">
            <title>MyDay</title>
            <description>Stenfilcon A contact lenses worn for 16 hours in Period 1, Period 2, or Period 3</description>
          </group>
          <group group_id="O3">
            <title>Clariti 1day</title>
            <description>Somofilcon A contact lenses worn for 16 hours in Period 1, Period 2, or Period 3</description>
          </group>
        </group_list>
        <measure>
          <title>Average Coefficient of Friction of Worn Lenses at 16 Hours</title>
          <description>Worn contact lenses were removed from the participant's eye and the coefficient of friction was measured by the inclined plane method. A lower coefficient of friction may indicate higher contact lens lubricity. The ex-vivo lubricity was carried out on one lens (one eye) only.</description>
          <population>Intention to treat participants with non-missing observations</population>
          <units>unitless</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0602" spread="0.00474"/>
                    <measurement group_id="O2" value="0.0576" spread="0.00338"/>
                    <measurement group_id="O3" value="0.0578" spread="0.00439"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Coefficient of Friction of Unworn Lenses</title>
        <description>Unworn contact lenses were removed from the commercial packaging and the coefficient of friction of the unworn lenses was measured by the inclined plane method. A lower coefficient of friction may indicate higher contact lens lubricity.</description>
        <time_frame>Day 1 (each product)</time_frame>
        <population>Intention to treat participants with non-missing observations</population>
        <group_list>
          <group group_id="O1">
            <title>TruEye</title>
            <description>Narafilcon A contact lenses</description>
          </group>
          <group group_id="O2">
            <title>MyDay</title>
            <description>Stenfilcon A contact lenses</description>
          </group>
          <group group_id="O3">
            <title>Clariti 1day</title>
            <description>Somofilcon A contact lenses</description>
          </group>
        </group_list>
        <measure>
          <title>Average Coefficient of Friction of Unworn Lenses</title>
          <description>Unworn contact lenses were removed from the commercial packaging and the coefficient of friction of the unworn lenses was measured by the inclined plane method. A lower coefficient of friction may indicate higher contact lens lubricity.</description>
          <population>Intention to treat participants with non-missing observations</population>
          <units>unitless</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>contact lenses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0571" spread="0.00324"/>
                    <measurement group_id="O2" value="0.0571" spread="0.00260"/>
                    <measurement group_id="O3" value="0.0552" spread="0.00305"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events (AEs) were collected for the duration of the study from the signing of informed consent (up to 17 days). This analysis population includes all participants exposed to investigational product.</time_frame>
      <desc>AEs were defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical signs, whether or not related to the medical device, obtained through solicited and spontaneous comments from all exposed participants and reported based on the treatment received. Ocular AEs are presented for both eyes combined.</desc>
      <group_list>
        <group group_id="E1">
          <title>TruEye</title>
          <description>Narafilcon A contact lenses worn bilaterally for 1 day (16 hours) in Period 1, Period 2, or Period 3</description>
        </group>
        <group group_id="E2">
          <title>MyDay</title>
          <description>Stenfilcon A contact lenses worn bilaterally for 1 day (16 hours) in Period 1, Period 2, or Period 3</description>
        </group>
        <group group_id="E3">
          <title>Clariti 1day</title>
          <description>Somofilcon A contact lenses worn bilaterally for 1 day (16 hours) in Period 1, Period 2, or Period 3</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Global Medical Affairs Franchise Head, Vision Care</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>alcon.medinfo@alcon.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

